Stanford University School of Medicine
Stanford, California, 94305, United States
NCT Number: NCT01323868
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
Looking for future studies?
Notify MeAll sexes
Observational
Stanford, California, 94305, United States
Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).
Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients admitted to Stanford Hospital that have a systemic blood-borne infection and on which an Ophthalmology consult to rule out endogenous endophthalmitis is performed will be included in the study. Exclusion Criteria:None
Time frame: 1 day
Time frame: 2 wk
Stanford University
Other
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07717944
Endophthalmitis, Endophthalmitis Postoperative
Banhā, Benha, Egypt
View Trial DetailsNCT07514845
Endophthalmitis, Eye Diseases
Brest, France
View Trial DetailsNCT06755177
Endophthalmitis, Eye Diseases
Wuhan, Hubei, China
View Trial DetailsNCT04192994
Endophthalmitis, Eye Diseases
São Paulo, Brazil
View Trial Details